Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use
More than 50 years after Propranolol was introduced to the pharmaceutical market as a drug that can lower the heart rate, beta-blockers (BAB) are still widely used in the pharmacotherapy of cardiovascular diseases. However, the use of BAB has a number of limitations, first of all, due to adverse dru...
Main Authors: | A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2591 |
Similar Items
-
Could beta blocker use in elderly hypertensive patients reduce risk of skin cancers?
by: Habibullah Aktas, et al.
Published: (2019-12-01) -
Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
by: Rachel Massalee, et al.
Published: (2024-01-01) -
PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01) -
Analysis of adverse reactions of antihypertensive drugs registered in the Republic of Crimea for the period 2011-2016
by: A. V. Matveev, et al.
Published: (2019-04-01) -
THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)